Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex

Ning Liang, Chi Zhang, Patricia Dill, Ganna Panasyuk, Delphine Pion, Vonda Koka, Morgan Gallazzini, Eric N. Olson, Hilaire Lam, Elizabeth P. Henske, Zheng Dong, Udayan Apte, Nicolas Pallet, Randy L. Johnson, Fabiola Terzi, David J. Kwiatkowski, Jean Yves Scoazec, Guido Martignoni, Mario Pende

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Genetic studies have shown that the tuberous sclerosis complex (TSC) 1-TSC2-mammalian target of Rapamycin (mTOR) and the Hippo-Yes-associated protein 1 (YAP) pathways are master regulators of organ size, which are often involved in tumorigenesis. The crosstalk between these signal transduction pathways in coordinating environmental cues, such as nutritional status and mechanical constraints, is crucial for tissue growth. Whether and how mTOR regulates YAP remains elusive. Here we describe a novel mouse model of TSC which develops renal mesenchymal lesions recapitulating human perivascular epithelioid cell tumors (PEComas) from patients with TSC. We identify that YAP is up-regulated by mTOR in mouse and human PEComas. YAP inhibition blunts abnormal proliferation and induces apoptosis of TSC1-TSC2-deficient cells, both in culture and in mosaic Tsc1 mutant mice. We further delineate that YAP accumulation in TSC1/TSC2-deficient cells is due to impaired degradation of the protein by the autophagosome/lysosome system. Thus, the regulation of YAP by mTOR and autophagy is a novel mechanism of growth control, matching YAP activity with nutrient availability under growth-permissive conditions. YAP may serve as a potential therapeutic target for TSC and other diseases with dysregulated mTOR activity.

Original languageEnglish (US)
Pages (from-to)2249-2263
Number of pages15
JournalJournal of Experimental Medicine
Volume211
Issue number11
DOIs
StatePublished - Jan 1 2014

Fingerprint

Tuberous Sclerosis
Autophagy
Sirolimus
Perivascular Epithelioid Cell Neoplasms
Proteins
Therapeutics
Growth
Organ Size
Lysosomes
Nutritional Status
Proteolysis
Cues
Signal Transduction
Carcinogenesis
Apoptosis
Kidney
Food

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Liang, N., Zhang, C., Dill, P., Panasyuk, G., Pion, D., Koka, V., ... Pende, M. (2014). Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. Journal of Experimental Medicine, 211(11), 2249-2263. https://doi.org/10.1084/jem.20140341

Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. / Liang, Ning; Zhang, Chi; Dill, Patricia; Panasyuk, Ganna; Pion, Delphine; Koka, Vonda; Gallazzini, Morgan; Olson, Eric N.; Lam, Hilaire; Henske, Elizabeth P.; Dong, Zheng; Apte, Udayan; Pallet, Nicolas; Johnson, Randy L.; Terzi, Fabiola; Kwiatkowski, David J.; Scoazec, Jean Yves; Martignoni, Guido; Pende, Mario.

In: Journal of Experimental Medicine, Vol. 211, No. 11, 01.01.2014, p. 2249-2263.

Research output: Contribution to journalArticle

Liang, N, Zhang, C, Dill, P, Panasyuk, G, Pion, D, Koka, V, Gallazzini, M, Olson, EN, Lam, H, Henske, EP, Dong, Z, Apte, U, Pallet, N, Johnson, RL, Terzi, F, Kwiatkowski, DJ, Scoazec, JY, Martignoni, G & Pende, M 2014, 'Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex', Journal of Experimental Medicine, vol. 211, no. 11, pp. 2249-2263. https://doi.org/10.1084/jem.20140341
Liang, Ning ; Zhang, Chi ; Dill, Patricia ; Panasyuk, Ganna ; Pion, Delphine ; Koka, Vonda ; Gallazzini, Morgan ; Olson, Eric N. ; Lam, Hilaire ; Henske, Elizabeth P. ; Dong, Zheng ; Apte, Udayan ; Pallet, Nicolas ; Johnson, Randy L. ; Terzi, Fabiola ; Kwiatkowski, David J. ; Scoazec, Jean Yves ; Martignoni, Guido ; Pende, Mario. / Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. In: Journal of Experimental Medicine. 2014 ; Vol. 211, No. 11. pp. 2249-2263.
@article{963b02c72b204a9ea9995aced13b3d5f,
title = "Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex",
abstract = "Genetic studies have shown that the tuberous sclerosis complex (TSC) 1-TSC2-mammalian target of Rapamycin (mTOR) and the Hippo-Yes-associated protein 1 (YAP) pathways are master regulators of organ size, which are often involved in tumorigenesis. The crosstalk between these signal transduction pathways in coordinating environmental cues, such as nutritional status and mechanical constraints, is crucial for tissue growth. Whether and how mTOR regulates YAP remains elusive. Here we describe a novel mouse model of TSC which develops renal mesenchymal lesions recapitulating human perivascular epithelioid cell tumors (PEComas) from patients with TSC. We identify that YAP is up-regulated by mTOR in mouse and human PEComas. YAP inhibition blunts abnormal proliferation and induces apoptosis of TSC1-TSC2-deficient cells, both in culture and in mosaic Tsc1 mutant mice. We further delineate that YAP accumulation in TSC1/TSC2-deficient cells is due to impaired degradation of the protein by the autophagosome/lysosome system. Thus, the regulation of YAP by mTOR and autophagy is a novel mechanism of growth control, matching YAP activity with nutrient availability under growth-permissive conditions. YAP may serve as a potential therapeutic target for TSC and other diseases with dysregulated mTOR activity.",
author = "Ning Liang and Chi Zhang and Patricia Dill and Ganna Panasyuk and Delphine Pion and Vonda Koka and Morgan Gallazzini and Olson, {Eric N.} and Hilaire Lam and Henske, {Elizabeth P.} and Zheng Dong and Udayan Apte and Nicolas Pallet and Johnson, {Randy L.} and Fabiola Terzi and Kwiatkowski, {David J.} and Scoazec, {Jean Yves} and Guido Martignoni and Mario Pende",
year = "2014",
month = "1",
day = "1",
doi = "10.1084/jem.20140341",
language = "English (US)",
volume = "211",
pages = "2249--2263",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "11",

}

TY - JOUR

T1 - Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex

AU - Liang, Ning

AU - Zhang, Chi

AU - Dill, Patricia

AU - Panasyuk, Ganna

AU - Pion, Delphine

AU - Koka, Vonda

AU - Gallazzini, Morgan

AU - Olson, Eric N.

AU - Lam, Hilaire

AU - Henske, Elizabeth P.

AU - Dong, Zheng

AU - Apte, Udayan

AU - Pallet, Nicolas

AU - Johnson, Randy L.

AU - Terzi, Fabiola

AU - Kwiatkowski, David J.

AU - Scoazec, Jean Yves

AU - Martignoni, Guido

AU - Pende, Mario

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Genetic studies have shown that the tuberous sclerosis complex (TSC) 1-TSC2-mammalian target of Rapamycin (mTOR) and the Hippo-Yes-associated protein 1 (YAP) pathways are master regulators of organ size, which are often involved in tumorigenesis. The crosstalk between these signal transduction pathways in coordinating environmental cues, such as nutritional status and mechanical constraints, is crucial for tissue growth. Whether and how mTOR regulates YAP remains elusive. Here we describe a novel mouse model of TSC which develops renal mesenchymal lesions recapitulating human perivascular epithelioid cell tumors (PEComas) from patients with TSC. We identify that YAP is up-regulated by mTOR in mouse and human PEComas. YAP inhibition blunts abnormal proliferation and induces apoptosis of TSC1-TSC2-deficient cells, both in culture and in mosaic Tsc1 mutant mice. We further delineate that YAP accumulation in TSC1/TSC2-deficient cells is due to impaired degradation of the protein by the autophagosome/lysosome system. Thus, the regulation of YAP by mTOR and autophagy is a novel mechanism of growth control, matching YAP activity with nutrient availability under growth-permissive conditions. YAP may serve as a potential therapeutic target for TSC and other diseases with dysregulated mTOR activity.

AB - Genetic studies have shown that the tuberous sclerosis complex (TSC) 1-TSC2-mammalian target of Rapamycin (mTOR) and the Hippo-Yes-associated protein 1 (YAP) pathways are master regulators of organ size, which are often involved in tumorigenesis. The crosstalk between these signal transduction pathways in coordinating environmental cues, such as nutritional status and mechanical constraints, is crucial for tissue growth. Whether and how mTOR regulates YAP remains elusive. Here we describe a novel mouse model of TSC which develops renal mesenchymal lesions recapitulating human perivascular epithelioid cell tumors (PEComas) from patients with TSC. We identify that YAP is up-regulated by mTOR in mouse and human PEComas. YAP inhibition blunts abnormal proliferation and induces apoptosis of TSC1-TSC2-deficient cells, both in culture and in mosaic Tsc1 mutant mice. We further delineate that YAP accumulation in TSC1/TSC2-deficient cells is due to impaired degradation of the protein by the autophagosome/lysosome system. Thus, the regulation of YAP by mTOR and autophagy is a novel mechanism of growth control, matching YAP activity with nutrient availability under growth-permissive conditions. YAP may serve as a potential therapeutic target for TSC and other diseases with dysregulated mTOR activity.

UR - http://www.scopus.com/inward/record.url?scp=84908258052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908258052&partnerID=8YFLogxK

U2 - 10.1084/jem.20140341

DO - 10.1084/jem.20140341

M3 - Article

C2 - 25288394

AN - SCOPUS:84908258052

VL - 211

SP - 2249

EP - 2263

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 11

ER -